Reviva Pharmaceuticals Holdings, Inc. SEC filings RVPH
Reviva Pharmaceuticals Holdings, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
May 13, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 15, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 19, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 5, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Jan 23, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
Dec 23, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 17, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 19, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Auditor change
|
Jun 6, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Material agreement
|
May 30, 2025 | May 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 18, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Dec 12, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2024 | Sep 15, 2024 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Aug 22, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 21, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Material agreement
|
May 29, 2024 | May 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Results of operations, Restatement
|
Apr 15, 2024 | Apr 12, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 17, 2023 | Nov 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Nov 14, 2023 | Nov 13, 2023 |
| 8-K/A |
Amended current report
Auditor change
|
Nov 14, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 17, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Auditor change
|
Jul 24, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Nov 14, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 7, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Agreement ended
|
Jul 28, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 27, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Other events
|
Feb 1, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 26, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2021 | Dec 8, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K | Current report | Sep 20, 2021 | Sep 17, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Results of operations, Restatement
|
May 7, 2021 | May 7, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2021 | Apr 14, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 22, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Other events
|
Mar 4, 2021 | Mar 4, 2021 |
| 8-K/A |
Amended current report
Auditor change, Bylaw or fiscal year change
|
Jan 20, 2021 | Dec 14, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Bylaw or fiscal year change
|
Dec 18, 2020 | Dec 14, 2020 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Dec 14, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Dec 9, 2020 | Dec 8, 2020 |
| 8-K |
Current report
Other events
|
Nov 19, 2020 | Nov 18, 2020 |
| 8-K |
Current report
New debt
|
Nov 13, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Other events
|
Nov 5, 2020 | Nov 4, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 27, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 22, 2020 | Oct 21, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2020 | Oct 6, 2020 |
| 8-K |
Current report
New debt, Shareholder vote results, Regulation FD disclosure
|
Sep 25, 2020 | Sep 25, 2020 |
| 8-K |
Current report
Other events
|
Sep 14, 2020 | Sep 14, 2020 |
| 8-K |
Current report
New debt
|
Aug 18, 2020 | Aug 18, 2020 |
| 8-K |
Current report
New debt
|
Jul 29, 2020 | Jul 24, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2020 | Jul 29, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 24, 2020 | Jul 20, 2020 |
| 8-K |
Current report
Other events
|
Jul 21, 2020 | Jul 21, 2020 |
| 8-K |
Current report
New debt, Shareholder vote results, Regulation FD disclosure
|
May 21, 2020 | May 21, 2020 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Feb 18, 2020 | Feb 18, 2020 |
| 8-K |
Current report
New debt
|
Feb 14, 2020 | Feb 10, 2020 |
| 8-K |
Current report
Other events
|
Oct 17, 2018 | Oct 17, 2018 |
| 8-K |
Current report
Other events
|
Sep 5, 2018 | Aug 30, 2018 |
| 8-K |
Current report
Other events
|
Aug 29, 2018 | Aug 23, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Aug 24, 2018 | Aug 20, 2018 |
Showing 97 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RVPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cupertino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1742927
- Former names
- Tenzing Acquisition Corp. (until Dec 14, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.